Novartis withdraws application for pre-pandemic vaccine

Novartis Vaccines and Diagnostics, a unit of Novartis, has told the European Medicines Agency (EMEA) that it is withdrawing its marketing authorisation application for Aflunov, a pre-pandemic vaccine.